Shanghai MicroPort Endovascular MedTech Co., Ltd.
SSE:688016.SS
89.23 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,206.327 | 1,175.172 | 896.5 | 684.631 | 470.252 | 333.733 | 231.127 | 165.135 | 125.327 |
| Cost of Revenue
| 325.577 | 285.932 | 222.513 | 150.281 | 98.282 | 68.932 | 48.966 | 36.781 | 29.64 |
| Gross Profit
| 880.75 | 889.24 | 673.988 | 534.349 | 371.971 | 264.801 | 182.162 | 128.354 | 95.686 |
| Gross Profit Ratio
| 0.73 | 0.757 | 0.752 | 0.78 | 0.791 | 0.793 | 0.788 | 0.777 | 0.763 |
| Reseach & Development Expenses
| 93.77 | 178.57 | 137.537 | 102.266 | 73.005 | 49.638 | 29.029 | 20.136 | 20.076 |
| General & Administrative Expenses
| 34.175 | 19.987 | 18.412 | 10.439 | 6.211 | 5.783 | 6.903 | 6.08 | 5.5 |
| Selling & Marketing Expenses
| 80.118 | 68.549 | 104.004 | 75.668 | 59.516 | 55.437 | 40.202 | 25.966 | 22.962 |
| SG&A
| 114.294 | 177.448 | 122.417 | 86.106 | 65.727 | 61.22 | 47.105 | 32.046 | 28.461 |
| Other Expenses
| 11.514 | -37.675 | 8.98 | 5.719 | 2.046 | -4.123 | 0.004 | 0.111 | 2.976 |
| Operating Expenses
| 219.577 | 327.418 | 268.933 | 194.091 | 140.778 | 106.735 | 75.997 | 52.911 | 50.055 |
| Operating Income
| 661.172 | 573.854 | 415.214 | 362.776 | 249.935 | 164.266 | 104.847 | 73.923 | 44.855 |
| Operating Income Ratio
| 0.548 | 0.488 | 0.463 | 0.53 | 0.531 | 0.492 | 0.454 | 0.448 | 0.358 |
| Total Other Income Expenses Net
| -8.979 | -1.587 | -1.319 | -1.116 | -0.382 | 0.07 | 0.004 | 0.117 | 2.967 |
| Income Before Tax
| 652.194 | 572.267 | 413.895 | 361.66 | 249.553 | 164.336 | 104.851 | 74.039 | 47.822 |
| Income Before Tax Ratio
| 0.541 | 0.487 | 0.462 | 0.528 | 0.531 | 0.492 | 0.454 | 0.448 | 0.382 |
| Income Tax Expense
| 159.446 | 85.05 | 61.845 | 48.148 | 34.94 | 22.581 | 14.203 | 10.653 | 6.708 |
| Net Income
| 502.1 | 492.432 | 356.878 | 315.856 | 214.613 | 141.756 | 90.648 | 63.386 | 41.114 |
| Net Income Ratio
| 0.416 | 0.419 | 0.398 | 0.461 | 0.456 | 0.425 | 0.392 | 0.384 | 0.328 |
| EPS
| 4.07 | 4.57 | 4.96 | 4.39 | 2.98 | 1.97 | 1.68 | 1.17 | 0.76 |
| EPS Diluted
| 4.07 | 6.37 | 4.96 | 4.39 | 2.98 | 1.97 | 1.68 | 1.17 | 0.76 |
| EBITDA
| 703.848 | 624.299 | 469.522 | 390.165 | 265.278 | 175.102 | 108.924 | 75.527 | 47.376 |
| EBITDA Ratio
| 0.583 | 0.531 | 0.524 | 0.57 | 0.564 | 0.525 | 0.471 | 0.457 | 0.378 |